FIELD: pharmacology. SUBSTANCE: particles being dispersed consist of crystalline antitumor substances. Surface modifier is adsorbed on particle surface in amount 0.1 to 90 wt % that is high enough to retain average effective particle size below 1000 nm. Surface modifier represents polyvinyl alcohol, tetrafunctional block copolymer resulting from successive addition of ethylene oxide and propylene oxide to ethylenediamine, gum Arabic, ethylene oxide/propylene oxide block copolymer, fatty acid ester with polyoxyethylenesorbitan, and fatty acid ester with sorbitan. EFFECT: reduced toxicity and/or increased activity, and enabled intravenous administration. 16 cl, 23 ex
Title | Year | Author | Number |
---|---|---|---|
PARTICLES INCLUDING POORLY DISSOLVING CRYSTALLINE THERAPEUTIC OR DIAGNOSTIC AGENT AND METHOD OF THEIR PRODUCTION | 1993 |
|
RU2124886C1 |
METHOD OF DRUG PARTICLE PREPARING | 1993 |
|
RU2122405C1 |
THERAPEUTIC AND DIAGNOSIS COMPOSITION | 1993 |
|
RU2114612C1 |
LIPOSOME AEROSOLS WITH SMALL-SIZE PARTICLES FOR TRANSPORTING ANTICANCER THERAPEUTIC PREPARATIONS | 1998 |
|
RU2223749C2 |
POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS | 2006 |
|
RU2472812C2 |
COMPOSITIONS AND WAYS OF PHARMACOLOGICAL AGENTS DELIVERY | 2003 |
|
RU2361615C2 |
MEDICINAL SUBSTANCE PARTICLES, METHOD OF THEIR PREPARING, STABLE DISPERSION, AGENT CONTAINING MEDICINAL SUBSTANCE AS PARTICLES | 1992 |
|
RU2066553C1 |
COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS | 2009 |
|
RU2522977C2 |
COMBINED CHEMOTHERAPY | 2001 |
|
RU2284818C2 |
METHOD OF ENHANCEMENT OF CHEMOTHERAPEUTIC AGENT CYTOTOXICITY, SET FOR TREATMENT | 1994 |
|
RU2148406C1 |
Authors
Dates
1999-05-27—Published
1993-06-30—Filed